| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 健康服务(元) | 36,950,435.08 | 95,931,992.28 | 55,140,747.01 |
| 医药零售(元) | 584,523,442.86 | 1,239,168,667.21 | 619,048,579.07 |
| 医药批发(元) | 368,882,022.35 | 1,724,181,532.67 | 911,154,326.79 |
| 医药制造-原料药销售(元) | 101,911,900.35 | 253,452,322.08 | 149,479,422.22 |
| 医药制造-制剂销售(元) | 180,698,908.15 | 411,707,474.16 | 216,322,514.22 |
| 营业成本(元) | |||
| 健康服务(元) | - | 96,103,840.90 | - |
| 医药零售(元) | 469,512,090.23 | 999,330,721.49 | 498,052,584.32 |
| 医药批发(元) | - | 1,578,252,078.66 | - |
| 医药制造-原料药销售(元) | 59,312,704.57 | 201,035,342.52 | 119,218,173.29 |
| 医药制造-制剂销售(元) | 72,786,320.19 | 155,551,504.08 | 83,818,709.77 |
| 毛利(元) | |||
| 健康服务(元) | - | -171,848.62 | - |
| 医药零售(元) | 115,011,352.63 | 239,837,945.72 | 120,995,994.75 |
| 医药批发(元) | - | 145,929,454.01 | - |
| 医药制造-原料药销售(元) | 42,599,195.78 | 52,416,979.56 | 30,261,248.93 |
| 医药制造-制剂销售(元) | 107,912,587.96 | 256,155,970.08 | 132,503,804.45 |
| 毛利率(%) | |||
| 健康服务(%) | - | -0.18 | - |
| 医药零售(%) | 19.68 | 19.35 | 19.55 |
| 医药批发(%) | - | 8.46 | - |
| 医药制造-原料药销售(%) | 41.80 | 20.68 | 20.24 |
| 医药制造-制剂销售(%) | 59.72 | 62.22 | 61.25 |
| 收入构成(%) | |||
| 健康服务(%) | 2.90 | 2.58 | 2.83 |
| 医药零售(%) | 45.92 | 33.27 | 31.73 |
| 医药批发(%) | 28.98 | 46.29 | 46.70 |
| 医药制造-原料药销售(%) | 8.01 | 6.81 | 7.66 |
| 医药制造-制剂销售(%) | 14.20 | 11.05 | 11.09 |
| 毛利构成(%) | |||
| 健康服务(%) | 0.00 | -0.02 | 0.00 |
| 医药零售(%) | 43.32 | 34.55 | 42.64 |
| 医药批发(%) | 0.00 | 21.02 | 0.00 |
| 医药制造-原料药销售(%) | 16.04 | 7.55 | 10.66 |
| 医药制造-制剂销售(%) | 40.64 | 36.90 | 46.70 |